Home For HCPs Clinical Results

Clinical Results with Leva Therapy

Evidence-Based Symptom Improvement  Demonstrates Leva’s Effectiveness

A pivotal 8-week prospective, randomized controlled trial (RCT) with 299 participants, published in ACOG’s Green Journal in April 2022, demonstrated that pelvic floor muscle training (PFMT) guided by Leva is statistically superior to at home pelvic floor muscle training alone in reducing frequency of UI episodes and delivered greater UI symptom improvement1. On average, Leva users saw:

0 %

Reduction

in bladder leakage episodes by 8 weeks.
0

Weeks

Results as early as 4 weeks into treatment.
Clinically significant improvement

regardless of UI symptom severity.

Read The Full Study

Leva users see significant symptom relief which is comparable to supervised PFMT in Cochrane Reviews2

Want to learn about how Leva can help your patients or how to get started prescribing Leva?

Contact Us

Recognized as a 2023 medical breakthrough in women’s health by AARP.

  1. Weinstein, MM, Dunivan, G, Guaderrama, NM, Richter, HE. Digital Therapeutic Device for Urinary incontinence: A Randomized Controlled Trial [published online ahead of print, 2022 March 10]. Obstet Gynecol. Doi: 10.1097/AOG.0000000000004725.
  2. Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018;10(10):CD005654. Published 2018 Oct 4. doi:10.1002/14651858.CD005654.pub4.
  3. Weinstein MM, Dunivan GC, Guaderrama NM, Richter HE. A Motion-based Device Urinary Incontinence Treatment: A Longitudinal Analysis at 18 and 24 Months. Int Urogynecol J. Published online January 22, 2024. doi:10.1007/s00192-023-05721-z.
  4. Hall E, Keyser L, McKinney J, Pulliam S, Weinstein M. Real-World Evidence From a Digital Health Treatment Program for Female Urinary Incontinence: Observational Study of Outcomes Following User-Centered Product Design. JMIR Form Res. 2024 Jun 27;8:e58551. doi: 10.2196/58551. Erratum in: JMIR Form Res. 2024 Aug 27;8:e65416. doi: 10.2196/65416. PMID: 38935967; PMCID: PMC11240060.